We develop and distribute dermatological products for the medical, cosmetic and the retail markets. We identify common medical problems that do not respond well to present medical treatments. Once the common clinical problem is identified as having weak treatments, we develop a better and proprietary treatment and then introduce this treatment to the medical community. If our product is well received in the medical community for a period of two to five years, we then evaluate the possibility of introducing the product to the cosmetic and retail market segments.
TOPICAINE® topical anesthetic gel numbs the skin with rapid onset and great efficacy proven in clinical trials. No more pain with TOPICAINE numbing gel. Used by plastic surgeons, dermatologists, electrologists and all hair removal specialists. Contains lidocaine 4% and is an over-the-counter anesthetic for general skin use. TOPICAINE 5 contains lidocaine 5% and is approved for anorectal use.
Del-Ray Dermatologicals manufactures and markets prescription (Ala Scalp/Ala Quin, etc.) and OTC drugs (medicated shampoos, cleansers, sunscreens, and Ulcerease anesthetic mouth rinse). Blue Lizard Australian Suncream is the premier broad spectrum photo protection product blocking 99.83% of UVA light and also providing an SPF 30. Developed in Australia, Blue Lizard Australian Suncream uses the most technologically advanced ingredients from around the world to provide the best protection through both the UVB and UVA spectrum. Blue Lizard Australian Suncream is packaged in a patented bottle that changes color (blue/pink) when exposed to UVA radiation. This bottle is an indicator of UVA exposure and therefore helps reinforce the need to apply sunscreen throughout the year whenever the bottle changes color.
Genesis Pharmaceutical is committed to providing everything you need to succeed with the Glytone Skin Rejuvenation System. From thorough training for you and your staff to our exclusive inventory control system, Genesis helps you get started and makes it easy to stay with Glytone. You can also call on us for practical, ethical marketing and promotion ideas that you can use with integrity.
PharmaDerm, a division of Nycomed US, is a specialty pharmaceutical company dedicated to developing and commercializing prescription products to treat diseases and conditions of the skin-the largest organ of the human body. Our goal is to pursue development of products that will help improve the lives of patients with skin disease. Nycomed US is a leading manufacturer of topical prescription products pharmaceutical products in the United States and is uniquely positioned as a fully integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, sales and marketing. KEROL(TM) Emulsion and KEROL(TM) ZX are for external use only. Avoid contact with eyes, lips or mucous membranes. Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.
DermaPet was developed by Steven A. Melman, V.M.D., a leading animal dermatology and psychology referralist. He is an internationally know lecturer, author and referral clinician with clinics in Washington DC, and Palm Springs, CA. DermaPet products are all natural, no dyes nor animal by-products, natural fragrances, cruelty-free, pH balanced, non-polluting, biodegradable, environmentally sensitive, and packaged in recyclable containers.
http://www.primepharmaceutical.com
Prime Pharmaceutical Corporation is a dermatological, pharmaceutical company that has developed a treatment incorporating the latest biotechnology, and is preparing to enter the North American psoriasis and eczema market. Prime is positioned to apply its innovative technology to the natural, proprietary OTC or prescription pharmaceutical markets for the treatment of a variety of conditions including psoriasis, eczema and other skin problems.
http://www.questpharmatech.com
Quest PharmaTech Inc. is engaged in the development and commercialization of new pharmaceutical products. The Company’s is developing a series of products for the treatment of cancer and dermatological conditions based on its photodynamic and sonodynamic therapy platform. Quest is developing these compounds as drugs, as well as developing means of activating and delivering them to target tissues. The Company’s lead product, SL017, is a topical formulation indicated for dermatology applications. A second product from the SonoLight platform, SL052, is an injectable formulation that is in late-stage pre-clinical development for prostate cancer treatment. Quest has entered into a license agreement with KMH Co., Ltd ("KMH") to market the Company's hair removal product, SL017, in Asia. (Source: ARS)
Crawford Pharmaceuticals is a leading supplier of dermatology products for a range of skin conditions. Crawford Pharmaceuticals Limited is a specialty pharmaceutical company dedicated to making effective dermatological treatments available to healthcare professionals and patients. By working with partner companies who are leaders in their respective fields and markets Crawford can offer innovative and valuable treatments across a range of dermatological conditions. Pharmaceutical products sales across major international markets are more than €250 billion of which dermatology products account for more than €8 billion. Crawford Healthcare is focusing efforts on developing domestic and international sales opportunities in this sector through organic growth and acquisition. Current key areas include Psoriasis, Eczema, Contact Dermatitis, Photodermatology and prevention of Photodamage. Current key areas include Acne, Contact Dermatitis, Eczema, Photodermatology, Psoriasis, Sun Protection and Vitiligo.
Hill Dermaceuticals, Inc. was established in 1943 and is based in Sanford, Florida. Hill is a pharmaceutical company that specializes in developing dermatology products for adults and children with difficult to treat skin diseases such as, scalp psoriasis, atopic dermatitis/eczema in children and adults and chronic, itchy ear problems. Hill is a leader in developing new drugs within dermatology. Our research and development has generated more new drug approvals ("NDAs") then all other dermatology companies combined. Hill's criterion for marketing a product is simple: It must work better then any other product It must be safer then any other product Patients will be able to afford it We manufacture, distribute and market our products throughout the United States, Canada and the Caribbean.
Axxess Pharma Inc. is a specialty pharmaceutical company headquartered in Markham, Ontario. The company was founded by Everett Sequeira who partnered with Dr. Ron Porter. Together, they have successfully developed commercial, scientific and regulatory components for an efficient pharmaceutical and diagnostic organization. Since 1997, Axxess Pharma has marketed and distributed various pharmaceutical products and diagnostic medical devices. Products are obtained through acquisition, licensing and distributorship arrangements and include the following:Axxess Pharma acquired and owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally; Axxess has licensed Monurol a single dose antibiotic, specific treatment for Urinary track infections with Zambon SPA Switzerland. And exclusive license for marketing, and distribution of Trans dermal patches, and cosmetic masks and patches with Caleb Pharma.
Episciences, Inc, was founded in 2002 and is based in Boise, Idaho. Episciences, Inc, integrates twenty-plus years of research into the development of a highly effective cosmeceutical, non-prescription, dermatological product line. This breakthrough product has been proven effective by over 12 independent clinical studies to reverse and prevent the effects of visible skin aging and certain common skin diseases. Epionce is a comprehensive and innovative skin wellness line designed to optimize the appearance and health of the skin by working at the core of the skin's own protective and reparative systems. Combining a unique sub-layer delivery system and patent-pending botanical formulations, Epionce is a new paradigm in skin wellness delivering: Powerful Therapy: Epionce strengthens your skin's own mechanisms, helping to improve function, restore the barrier and reverse destructive skin inflammation, delivering you beautiful, healthy skin. Patent Pending Formulations: Epionce unique therapeutic skin treatments contain patented active ingredient complexes for common skin diseases, conditions and aging. Proven Results: The effectiveness of Epionce has been proven in double-blind clinical trials conducted by independent, nationally recognized research organizations. Based on a solid scientific approach, the Epionce product line is retailed through dermatologists, plastic surgeons and other skin care professionals interested in improving the overall health of the skin and quality of life of their patients.
CYNACON/OCuSOFT® is a distributor of ophthalmic and dermatological products. The Company is known foremost for its OCuSOFT® Lid Scrub, a topical solution used for cleansing the periocular region in blepharitis conditions. The Company has relationships with a number of companies and sells products throughout the U.S. and Latin America.
At Cutanix, we are committed to carrying out comprehensive studies to ensure the safety of our products. All of our products are subjected to a rigorous toxicology testing program similar to that required by the FDA for prescription drugs. While such testing is expensive, it is necessary to ensure that the bioactive molecules incorporated into our skincare products are completely safe. Our toxicology studies include genetic analysis, skin and eye irritation, skin sensitization, and long-term repeated dose blood and tissue analysis.
Summers Labs is a small, innovative pharmaceutical company focusing on the treatment of skin problems. We address the needs of patients suffering from psoriasis, eczema, severe dry skin, diaper rash, acne and other problems affecting the skin, scalp and nails. Our products have grown almost exclusively through the recommendations of dermatologists. We also receive strong support from pediatricians for Triple Paste, our diaper rash treatment. Summers offers problem-solving products that offer at least one, but often several additional advantages over products from our larger competitors. As a smaller company, we can only afford to participate in categories where we can make a significant contribution. We gladly back our products with an unconditional, full refund guarantee. Patients and dermatologists rely on Summers Labs for short and long term safe control of chronic skin problems. If you see a product you think might help, I encourage you to order today. You'll be glad you did.
Teikoku Pharma USA is a world leader in innovative, high-quality drug delivery systems (TDS). We develop and manufacture patches, unit-dose jellies and liquids, creams and ointments, and other delivery products for numerous conditions and applications, such as pain management or cosmetic care. By applying our TDS technologies to existing actives or co-developing new formulations, Teikoku helps pharmaceutical companies extend patent protections, diversify product lines, provide better delivery mechanisms, and promote brand loyalty. Teikoku charts new territory in prescription, OTC, and medical device markets around the world, transforming ideas into ideally delivered products that carry a competitive edge in quality and innovation.
At Dow we focus only on topical products, so you know your product is in very experienced hands. After 30+ years, we know how to prevent or correct the unique problems that can occur during topical formulation development, scale-up and long term storage. In just the past 3 years we have helped 65 clients develop stable, elegant, scalable formulations that are disease compatible and penetrate the skin as required. This is accomplished with a team of formulation, analytical and drug transport scientists using Dow's unique formulation development process.
Cutanea Life Sciences is a development stage specialty pharmaceutical company whose mission is to strategically in-license novel, mid-stage candidates to treat diseased and aging skin conditions, aggressively advance their development and maximize intellectual property and therapeutic applications, in order to create market-leading products for out-license or commercialization. We seek to improve human health and appearance through enterprising initiatives, serving the collective interests of patients and medical professionals. Cutanea is committed to a holistic approach to drug and device development, realizing that maximum value creation emanates from the flawless execution of strategically designed development programs. Cutanea Life Science's core competencies include a team of professionals with more than 90 years of combined experience in developing and commercializing healthcare products. Over the past decade, the individuals comprising this team have played a critical role in securing the US approval and launch of six NDA products, one PMA class three medical device and various international registrations. Specific expertise includes formulation and analytical chemistry, pharmaceutical science, project management, regulatory affairs, quality assurance, clinical development and commercial operations. In addition to our core team, Cutanea is advised by a broad network of technical and commercial experts, as well as practicing physicians and key medical opinion leaders. Cutanea Life Sciences is a member of the family of bio/pharmaceutical companies founded in conjunction with Paramount BioSciences, Inc. This relationship provides the company further access to the resources and support needed to grow a successful drug development company.
Syntopix is a speciality pharmaceutical research and development company. We seek to identify compounds and develop products that treat dermatological conditions, principally acne and staphylococcal infections including MRSA. We are committed to improving the health and appearance of our consumers by offering safe and effective treatments of the highest quality, thereby creating value for our shareholders and employees.
Dermik's mission is to foster healthy skin and nails, and in turn, a healthy outlook for life. Dermik Laboratories conducts the North American business of sanofi-aventis Dermatology, the global dermatology unit of sanofi-aventis. Dermik has nearly 60 years of experience in the development, marketing, and distribution of innovative prescription pharmaceutical products. Dermik has created a new division, Dermik Aesthetics, that will focus on marketing innovative, enduring, and reliable treatments to improve appearance and well-being. Dermik's mission is to foster healthy-looking skin and in turn, a healthy outlook for life.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory